Does BORTEZOMIB Cause Transplant rejection? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Transplant rejection have been filed in association with BORTEZOMIB (bortezomib). This represents 0.1% of all adverse event reports for BORTEZOMIB.
48
Reports of Transplant rejection with BORTEZOMIB
0.1%
of all BORTEZOMIB reports
6
Deaths
11
Hospitalizations
How Dangerous Is Transplant rejection From BORTEZOMIB?
Of the 48 reports, 6 (12.5%) resulted in death, 11 (22.9%) required hospitalization, and 3 (6.3%) were considered life-threatening.
Is Transplant rejection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BORTEZOMIB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Transplant rejection?
TACROLIMUS (3,526)
MYCOPHENOLATE MOFETIL (2,500)
PREDNISONE (1,111)
CYCLOSPORINE (903)
PREDNISOLONE (860)
METHYLPREDNISOLONE (779)
SIROLIMUS (698)
BASILIXIMAB (554)
MYCOPHENOLIC ACID (445)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)
Which BORTEZOMIB Alternatives Have Lower Transplant rejection Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX